Focal Segmental Glomerulosclerosis (FSGS): Symptoms, Causes, Diagnosis & Treatment

What Is Focal Segmental Glomerulosclerosis (FSGS)?

What Is Focal Segmental Glomerulosclerosis (FSGS)?
iStock; Everyday Health

Focal segmental glomerulosclerosis (FSGS) is a rare type of kidney disease marked by scarring (thickening or hardening) of your glomeruli, the tiny filters in your kidneys. This scarring leads to a buildup of waste products, which can lead to health issues such as kidney failure.

There’s no cure for FSGS, but there are treatments to slow the progression of the disease. If kidney failure occurs, treatments include a kidney transplant or dialysis.

Types of FSGS

There are approximately one million glomeruli in the kidneys, but the scarring from FSGS doesn’t develop on all of them. The condition is known as “focal segmental glomerulosclerosis” because the scarring affects only some glomeruli (focal) and of these, only a portion of each glomerulus (segmental).

There are a few main types of FSGS.

  • Primary (idiopathic) FSGS is thought to be associated with an immune system abnormality that damages or dysregulates podocytes, specialized cells that support glomeruli, although experts aren’t entirely sure.

  • Secondary FSGS develops from a wide range of other conditions, such as obesity, diabetes, sickle cell disease, HIV infection, heroin use, and other kidney diseases. Controlling or treating the underlying condition can often help treat secondary FSGS.

  • Genetic FSGS is a rare hereditary form of FSGS caused by genetic mutations. You can develop genetic FSGS if both of your parents carry one or both copies of the altered gene, even if they do not have FSGS.

Illustrative graphic titled Signs and Symptoms of Focal Segmental Glomerulosclerosis (FSGS) shows Fatigue High Blood Pressure High Cholesterol Swelling Sudden Weight Gain Loss of Appetite Foamy or Bubbly Urine Increased Risk of Infection. Everyday Health

Signs and Symptoms of FSGS

FSGS doesn’t always cause noticeable symptoms, but most people experience one or more of the following signs or symptoms.

  • Foamy or bubbly urine (caused by excess protein)

  • Edema (swelling) in the legs, ankles, feet, or around the eyes
  • Sudden, unexplained weight gain
  • Fatigue
  • Loss of appetite
  • Increased risk of infection

  • High blood pressure
  • High cholesterol

Often, people with FSGS also have a kidney disorder called nephrotic syndrome, including high levels of protein in the urine and low levels of protein in the blood, along with edema and high cholesterol. FSGS is one of the leading causes of nephrotic syndrome, which affects more than 70 percent of people with FSGS.

Causes and Risk Factors of FSGS

There are several different causes of FSGS, which differ by type.

Primary FSGS likely develops when certain immune system substances in the blood (called circulating factors) damage specialized cells in the glomeruli called podocytes. Podocytes act as a kind of filtration system in the glomeruli, blocking large molecules such as proteins from passing through. Researchers are still trying to identify which circulating factors may be responsible and what causes them to develop.

With secondary FSGS, podocyte disruption may be the result of a number of other health factors, including:

  • Obesity
  • Sickle cell disease
  • Systemic diseases like diabetes, lupus, and high blood pressure
  • Intravenous heroin use
  • Other drug use, including lithium, anabolic steroids, and chemotherapy drugs called anthracyclines
  • HIV and other viral infections, such as hepatitis B and C, parvovirus, and COVID-19
  • Other kidney diseases

With genetic FSGS, certain mutations can affect the glomeruli, particularly mutations on the APOL1 gene. This can increase a person's risk of FSGS.

In the United States, FSGS occurs more frequently among males and people who are Black.

How Is FSGS Diagnosed?

To diagnose FSGS, your healthcare provider will review your medical and symptomatic history, conduct a clinical evaluation, and order various laboratory and imaging tests. These may include:

  • Urine tests to measure the amount of protein and other substances in your urine
  • Blood tests to assess your kidney function and the levels of waste products in your blood
  • Estimated glomerular filtration rate (eGFR), a specific blood test that measures how well your kidneys are filtering wastes from your body

  • Kidney biopsy, during which a tiny tissue sample is collected from your kidney and inspected under a microscope. This is the only way to definitively diagnose FSGS
  • Genetic testing, rarely, to determine whether you have genetic FSGS
If you have secondary FSGS, you may need further testing to determine if you have an underlying condition such as HIV or hepatitis. Knowing which type of FSGS you have will help guide treatment.

Treatment and Medication Options for FSGS

FSGS is treatable, but not curable, since scarred glomeruli cannot be repaired. The current FSGS treatments work by helping to control symptoms and protect glomeruli, which can slow disease progression and achieve remission.

Medication Options for FSGS

Currently, the only medication approved to treat FSGS (all types) without nephrotic syndrome is sparsentan (Filspari), which was approved by the U.S. Food and Drug Administration (FDA) in April 2026. The medication works by reducing proteinuria, or excess protein in the urine.

Immunosuppressants

For primary FSGS, high-dose corticosteroids like prednisone are used to reduce proteinuria. Some people achieve partial or full remission from this treatment alone.

If steroids are not fully effective or the side effects are too severe, your doctor may recommend another type of immunosuppressant drug called calcineurin inhibitors (CNIs), which includes cyclosporine (Gengraf, Neoral, Sandimmune) and tacrolimus (Astagraf XL, Envarsus XR). These drugs require close monitoring.

If you’re unable to use steroids or CNIs, alternative immunosuppressant drugs include:

Medications for Symptom Management

Various other drugs are used to help manage specific symptoms of FSGS, regardless of which type you have. These include:

  • Angiotensin-converting enzyme (ACE) inhibitors or angiotensin 2 receptor blockers (ARBs) to reduce blood pressure and proteinuria (these drugs should not be used with sparsentan)
  • Diuretics to remove excess salt and water from the body, decreasing swelling and blood pressure
  • Antibiotics like penicillin to prevent or treat infections

  • Statins or other medications to lower cholesterol

Other Treatment Options

If FSGS progresses, you may require treatments such as a kidney transplant. Sometimes, FSGS comes back after a kidney transplant, which is known as recurrence. If this occurs, you may receive plasmapheresis or other medications.

Kidney Transplant

A kidney transplant is a procedure that places a healthy kidney from a living or deceased donor into a person whose kidneys are no longer working effectively (for example, in someone who has kidney failure).

Research suggests up to 32 percent of people with primary FSGS experience post-transplant recurrence. And people with some types of genetic FSGS also have a high risk of post-transplant recurrence — up to 34 percent for those with an NPHS1 gene mutation, for example.

Plasmapheresis

Plasmapheresis, also known as plasma exchange, is a treatment option if you have recurrent FSGS. This procedure involves drawing out your blood, removing the fluid part of it (the plasma), replacing the plasma with donor plasma, and returning the treated blood to your body. This treatment may help decrease proteinuria and improve your response to other FSGS treatments.

Lifestyle Changes and Prevention of FSGS

There are no preventive measures for primary and genetic FSGS. But you can take steps to reduce your risk of some forms of secondary FSGS, such as by maintaining a healthy weight, treating underlying conditions that may cause FSGS, and avoiding heroin use.

There are, however, certain lifestyle changes that can help improve your kidney health and symptoms, slow disease progression, and reduce your risk of complications.

  • Quit smoking.
  • Avoid certain medications that may harm the kidneys (unless recommended by your provider), such as over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen, blood-thinners or anticoagulants, and antimicrobial drugs.

  • Maintain a healthy weight for your body.
  • Exercise regularly.
  • Follow a kidney-healthy diet that’s high in fruits and vegetables and low in sodium.
  • Monitor your intake of sodium, protein, fat, cholesterol, and fluid, maintaining levels recommended by your provider or a registered dietitian.
  • Keep blood sugar levels under control.

  • Reduce alcohol consumption.
  • Manage stress levels.

FSGS Prognosis

The prognosis of FSGS varies greatly from person to person, depending on a variety of factors such as disease severity (degree of proteinuria) and response to treatment.

While damaged glomeruli cannot be repaired, treatment can lead to improved kidney function or remission. Sometimes FSGS can worsen, causing the need for a kidney transplant.

Complications of FSGS

The proteins in your blood play an important role in transporting nutrients throughout your body and supporting your immune system. But when your glomeruli are unable to filter your blood properly, more protein gets filtered out of your blood and into your urine over time. This can lead to various, potentially significant complications, including:

  • High blood pressure
  • Anemia (low levels of healthy red blood cells)
  • Blood clots in the veins (venous thromboembolism)
  • Blood clots in the capillaries or arteries (thrombotic microangiopathy)
  • Recurrent infections
  • Malnutrition

  • Nephrotic syndrome
  • Kidney failure or end-stage kidney disease

The Takeaway

  • FSGS is a potentially life-threatening disease that affects the kidneys. Without adequate treatment, it can lead to kidney failure.
  • It’s not known what causes all types of FSGS, but some are caused by genetic mutations, while others are caused by secondary conditions such as viral infections and obesity.
  • While there is no cure for FSGS and the prognosis can vary, there are treatments available that can help you achieve partial or complete remission.

FAQ

Is there a cure for FSGS?

Generally, no, but remission is possible with treatment.

FSGS is a specific disease that causes scarring of the glomeruli (filtering units) in the kidneys, while nephrotic syndrome refers to a set of symptoms that indicate kidney damage. FSGS is a primary cause of nephrotic syndrome.

Yes, but this is rare. Genetic FSGS can be caused by genetic mutations that can be passed down in families, but most cases are caused by an unknown or unidentified immune system issue.

Resources We Trust

igor-kagan-bio

Igor Kagan, MD

Medical Reviewer

Igor Kagan, MD, is an an assistant clinical professor at UCLA. He spends the majority of his time seeing patients in various settings, such as outpatient clinics, inpatient rounds,...

Joseph Bennington-Castro

Author

Joseph Bennington-Castro is a science writer based in Hawaii. He has written well over a thousand articles for the general public on a wide range topics, including health, astronom...

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Focal Segmental Glomerulosclerosis (FSGS). Cleveland Clinic. September 19, 2023.
  2. Rout P et al. Focal Segmental Glomerulosclerosis. StatPearls. December 11, 2024.
  3. Focal Segmental Glomerulosclerosis: Understanding a Rare Kidney Disease. Mayo Clinic. March 16, 2026.
  4. Focal Segmental Glomerulosclerosis (FSGS). Mayo Clinic. January 31, 2025.
  5. Focal Segmental Glomerulosclerosis (FSGS): Symptoms, Causes and Treatment. American Kidney Fund. March 6, 2026.
  6. Focal Segmental Glomerulosclerosis (FSGS). Kidney Care UK. August 2025.
  7. Focal Segmental Glomerulosclerosis (FSGS). Nephcure.
  8. Gembillo G et al. Advances in the Pathophysiology and Treatment of Focal Segmental Glomerulosclerosis: the Importance of a Timely and Tailored Approach. World Journal of Nephrology. June 25, 2025.
  9. Fogo, A. Causes and Pathogenesis of Focal Segmental Glomerulosclerosis. Nature Reviews Nephrology. December 2, 2014.
  10. Focal Segmental Glomerulosclerosis (FSGS). National Kidney Foundation.
  11. Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS. Travere Therapeutics. April 13, 2026.
  12. Bonilla M et al. A Review of Focal Segmental Glomerulosclerosis Classification With a Focus on Genetic Associations. Kidney Medicine. June 2024.
  13. Focal Segmental Glomerulosclerosis (FSGS). UPMC. April 24, 2025.
  14. Safe Medicine Use With Chronic Kidney Disease. National Kidney Foundation. April 21, 2025.
  15. Understanding FSGS. Navigate FSGS.
  16. Focal Segmental Glomerulosclerosis. Penn Medicine. April 1, 2025.